In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— Michigan Advocates Push for RDAC. See details below.
— New PCORI Funding Announcements Open Tomorrow! Click here for additional details.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Journal: Improving Access to Gene Therapies. Click here to read the article.
— National Alliance for Caregiving Report Highlights Critical Need to Support Transplant Caregivers. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below. 
— Journal: Improving Access to Gene Therapies. Click here to read the article.
— National Alliance for Caregiving Report Highlights Critical Need to Support Transplant Caregivers. See details below.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— National Alliance for Caregiving Report Highlights Critical Need to Support Transplant Caregivers. See details below.
— Tomorrow! Join the 2024 CSC Utilization Management Summit. See details below.
— Oregon PDAB Claims it May Use evLYG, ICER Studies. See details below.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— Podcast: PIPC Joins The Bonnell Foundation to Discuss Rare Disease Legislation. Click here to listen to the podcast.
— Oregon PDAB Claims it May Use evLYG, ICER Studies. See details below.
— Join the 2024 CSC Utilization Management Summit on November 19. See details below.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— Podcast: PIPC Joins The Bonnell Foundation to Discuss Rare Disease Legislation. Click here to listen to the podcast.
— Oregon PDAB Claims it May Use evLYG, ICER Studies. See details below.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— PCORI Accepting Nominations for Methodology Committee: Applications Due Thursday! Click here to learn more and submit a nomination.
— Register: Achieving Health Justice Together. Click here to register.
— Oregon PDAB Claims it May Use evLYG, ICER Studies. See details below.
— PIPC Urges Washington PDAB to Reject Discriminatory Value Assessments. Click here to read the letter.
— PIPC Urges Maryland Legislators to Reject PDAB Upper Payment Limit Plan. Click here to read the letter.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Oregon PDAB Claims it May Use evLYG, ICER Studies. See details below.
— This Week! PCORI Annual Meeting October 22-23, 2024. See details below.
— PIPC Urges Washington PDAB to Reject Discriminatory Value Assessments. Click here to read the letter.
— PIPC Urges Maryland Legislators to Reject PDAB Upper Payment Limit Plan. Click here to read the letter.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— PCORI Accepting Nominations for Methodology Committee: Applications Due 10/31! Click here to learn more and submit a nomination.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— PIPC Urges Oregon PDAB to Reject Discriminatory Metrics. See details below.
— AUCD Webinar: What do Adults with Autism and Other Neurodevelopmental Disorders Value in Adult Neurodevelopmental Care? Click here to register.
— Next Week! PCORI Annual Meeting October 22-23, 2024. See details below.
— Global Coalition on Aging Publishes Best Practices for Patient Engagement in PDABs. Click here to view the report. 
— PCORI Accepting Nominations for Methodology Committee: Applications Due 10/31! Click here to learn more and submit a nomination.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— AUCD Webinar: What do Adults with Autism and Other Neurodevelopmental Disorders Value in Adult Neurodevelopmental Care? Click here to register.
— Coming Up Soon! PCORI Annual Meeting October 22-23, 2024. See details below.
— Global Coalition on Aging Publishes Best Practices for Patient Engagement in PDABs. Click here to view the report. 
— CMS To Receive ICER Study as Part of Medicare Drug Price Negotiation Program. See details below.
— PCORI Accepting Nominations for Methodology Committee. Click here to learn more and submit a nomination.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— CMS To Receive ICER Study as Part of Medicare Drug Price Negotiation Program. See details below.
— PCORI Accepting Nominations for Methodology Committee. Click here to learn more and submit a nomination.
— PCORI Engagement Awards: Letters of Intent Due Thursday! Click here to learn more.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Engagement Awards: Letters of Intent Due Thursday. See details below.
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— 38 Organizations Comment on Maryland PDAB UPL Plan. See details below.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— PCORI Annual Meeting October 22-23, 2024. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— 38 Organizations Comment on Maryland PDAB UPL Plan. Click here to view the letter.
— Register for Cancer Support Community's Second Annual Inflation Reduction Act (IRA) Stakeholder Summit. See details below.
— Register for AFPA National Policy & Advocacy Summit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders.  Click here to view.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...

— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— 38 Organizations Comment on Maryland PDAB UPL Plan. Click here to view the letter.
— Register for Cancer Support Community's Second Annual Inflation Reduction Act (IRA) Stakeholder Summit. See details below.
— Register for AFPA National Policy & Advocacy Summit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders.  Click here to view.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

​In this week's edition...
 
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders.  Click here to view.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Tune in Tomorrow! Advancing Health Equity Through Community-Engaged Research. Click here for additional details and to watch webinar.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— PIPC Submits Feedback on ICER Assessment of ATTR-CM Treatments. Click here to read the letter.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— ICHOM Looking for Patient Partners! See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Chairman Tony Coelho's Statement on Final Passage of H.R. 485. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— PIPC Submits Feedback on ICER Assessment of ATTR-CM Treatments. Click here to read the letter.
— PIPC Submits Comments on 'Cures 2.0.' RFI. See details below. 
— PCORI Annual Meeting October 22-23, 2024. See details below.
— NIH Lecture: Advancing Health Equity Through Community-Engaged Research. Click here for additional details and to watch webinar.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— PIPC Submits Comments on Medicare Drug Price Negotiation Implementation Guidance. See details below.
— Due Friday! AAAS Seeks Nominations for Working Group on Disability Inclusion and Anti-Ableism. See details below.
— ICHOM Looking for Patient Partners! See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Chairman Tony Coelho's Statement on Final Passage of H.R. 485. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.